PTHS

AS OF

Dec 24 closing price

Price

$26.50

Change

-$0.48 (-1.78%)

Capitalization

81.8M

61 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

PTHS

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

Pelthos Therapeutics (PTHS) Ownership - Who owns Pelthos Therapeutics?

Pelthos Therapeutics Inc is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

PTHS

Capitalization

81.8M

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

14.2M

Total Cash/Share

4.60

Total Debt

3.48M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

5.99%

Revenue

7.41M

ROE

N/A

Book Value

58.3M

P/B Ratio

1.40

Cash Flow

N/A

Earnings

-18.14

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

2.01

Current Revenue Per Employee

673272.75

Dividends Per Share - Security

N/A

EBITDA

-22.24M

Float

N/A

Float - Current

N/A

Gross Income Margin

51.92

Revenue To Assets

-36.68

Shares Held By Institutions

13.2M

Shares Outstanding - Current

3.09M

Total Liabilities

68.2M

Total Volume MTD

N/A

Value

-1

Gain YTD

313.417

View a ticker or compare two or three

Compare

PTHS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for PTHS

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details